ALEC
Price
$1.48
Change
-$0.02 (-1.33%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
149.99M
34 days until earnings call
BLTE
Price
$59.22
Change
-$0.68 (-1.14%)
Updated
Jun 27, 04:54 PM (EDT)
Capitalization
1.95B
40 days until earnings call
Interact to see
Advertisement

ALEC vs BLTE

Header iconALEC vs BLTE Comparison
Open Charts ALEC vs BLTEBanner chart's image
Alector
Price$1.48
Change-$0.02 (-1.33%)
Volume$10.8K
Capitalization149.99M
Belite Bio
Price$59.22
Change-$0.68 (-1.14%)
Volume$200
Capitalization1.95B
ALEC vs BLTE Comparison Chart in %
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. BLTE commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Buy and BLTE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ALEC: $1.50 vs. BLTE: $59.90)
Brand notoriety: ALEC and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 39% vs. BLTE: 188%
Market capitalization -- ALEC: $149.99M vs. BLTE: $1.95B
ALEC [@Biotechnology] is valued at $149.99M. BLTE’s [@Biotechnology] market capitalization is $1.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, ALEC is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while BLTE’s TA Score has 3 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 4 bearish.
  • BLTE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALEC is a better buy in the short-term than BLTE.

Price Growth

ALEC (@Biotechnology) experienced а +2.74% price change this week, while BLTE (@Biotechnology) price change was -0.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

ALEC is expected to report earnings on Jul 31, 2025.

BLTE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($1.95B) has a higher market cap than ALEC($150M). BLTE YTD gains are higher at: -5.071 vs. ALEC (-20.635). BLTE has higher annual earnings (EBITDA): -43.31M vs. ALEC (-137.59M). ALEC has higher revenues than BLTE: ALEC (88.3M) vs BLTE (0).
ALECBLTEALEC / BLTE
Capitalization150M1.95B8%
EBITDA-137.59M-43.31M318%
Gain YTD-20.635-5.071407%
P/E RatioN/AN/A-
Revenue88.3M0-
Total Cash355MN/A-
Total Debt41MN/A-
FUNDAMENTALS RATINGS
ALEC: Fundamental Ratings
ALEC
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALECBLTE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 17 days ago
80%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 17 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMUFX14.69N/A
N/A
Federated Hermes Muni and Stock Adv F
JSEAX21.44N/A
N/A
JPMorgan International Equity A
MNDFX8.24N/A
N/A
Manning & Napier Disciplined Value I
SGQCX41.10N/A
N/A
DWS International Growth C
MGKAX14.05N/A
N/A
Morgan Stanley Global Permanence A

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-1.96%
RAIN - BLTE
48%
Loosely correlated
+7.43%
ACOG - BLTE
24%
Poorly correlated
-3.76%
CLDX - BLTE
22%
Poorly correlated
-1.35%
APLS - BLTE
22%
Poorly correlated
+0.05%
ALEC - BLTE
22%
Poorly correlated
+0.67%
More